Latest Period
Q4 2025
CUSIP: 140755208
Latest Period
Q4 2025
Institutions Reporting
3
Shares (Excl. Options)
132
Price
$4.33
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 3 institutions filings for Q4 2025.
What is CUSIP 140755208?
CUSIP 140755208 identifies CARA - TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 140755208:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Sporos Bioventures LLC | 9% | $19,544,812 | 837,636 | Sporos Bioventures LLC | 15 Apr 2025 | |||
| Solas Tvardi Sidecar LLC | 8.1% | $4,050,047 | 761,287 | Solas Tvardi Sidecar LLC | 15 Apr 2025 | |||
| Tweardy David John | 7% | $3,470,757 | 652,398 | David J. Tweardy | 15 Apr 2025 | |||
| DePinho Ronald A | 6.7% | -20% | $24,413,770 | -$6,035,311 | 626,190 | -20% | Ronald A. DePinho | 30 Sep 2025 |
| Tweardy Samuel David | 3.4% | -67% | $7,365,343 | -$14,730,686 | 315,658 | -67% | Samuel D. Tweardy | 07 Jul 2025 |
As of 31 Dec 2025, 3 institutional investors reported holding 132 shares of TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA). This represents 0% of the company’s total 9,346,119 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$568 | $5.32 | 0 |
| 2025 Q4 | 132 | $568 | -$861,996 | $4.33 | 3 |
| 2025 Q3 | 22,165 | $862,745 | +$8,201 | $39.00 | 8 |
| 2025 Q2 | 21,929 | $511,606 | -$2,705,206 | $23.33 | 7 |
| 2025 Q1 | 633,363 | $3,211,465 | -$2,599,722 | $5.07 | 33 |
| 2024 Q4 | 1,075,203 | $6,580,102 | +$6,496,611 | $6.12 | 39 |
| 2024 Q3 | 250 | $77 | +$77 | $0.31 | 1 |